The global diabetes nutrition market includes food products and nutritional supplements recommended for people with diabetes. The market predominantly offers low sugar and low calorie food items along with high fibre foods that help manage blood glucose levels. Some of the commonly available diabetes nutrition products are low glycemic index bread, pasta, fruits, vegetables, gluten free snacks, protein bars and dietary supplements. The advantages of diabetes specific diet include controlled blood sugar level fluctuations and reduced risk of diabetes complications. As per the International Diabetes Federation, around 9.3% of adults aged between 20-79 years have diabetes and the number is projected to grow to 10.2% by 2030.

The Global Diabetes Nutrition Market is estimated to be valued at US$ 6588.59 Mn in 2024 and is expected to exhibit a CAGR of 4.0% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the diabetes nutrition market are Actavis, AbbVie Inc., Astellas Pharma Inc., Cara Therapeutics, EPI Health LLC, Galderma Laboratories LP, Ocera Therapeutics Inc., and Pfizer Inc., Sanofi, Trevi Therapeutics. These players are focussing on new product launches, strategic collaborations and mergers to strengthen their market position.

The growing diabetes patient population globally is driving the demand for diabetes specific dietary regime and nutritional management. Diabetes Nutrition Market Size As per IDF, around 1 in 11 adults across the globe has diabetes and majority cases remain undiagnosed. This growing patient base is encouraging sales of diabetes nutrition products.

Key market players are expanding their regional presence through partnerships with regional distributors to cater to the increasing needs of diabetes population across countries. With growing medical awareness and focus on preventive healthcare, demand for diabetes nutrition is expected to surge in developing markets in the forecast period.

Get more insights on This Topic- Diabetes Nutrition Market